HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
International Wellness Clinical Trials

Over The Counter, 14 June 2021 – Vitamin D, Immunity And COVID-19, With Prof Martin Hewison

  • Interviews

Executive Summary

In this edition of HBW Insight's new 'Over The Counter' podcast, David Ridley (Senior Editor, EU) talks to University of Birmingham professor Martin Hewison about vitamin D's immunity benefits, whether it can help prevent infection with or lessen the effects of COVID-19 and what industry can do to help researchers unlock the potential of this trending dietary supplement ingredient.


Open Media

 

Recommended Reading:

Vitamin D And COVID-19: Could 800IU A Day Be 'Goldilocks' Compromise?

Vitamin D Supplements For Children Present Overdose Risk, Say French Regulators

French Experts Call For Mass Vitamin D Supplementation To Fight COVID-19

UK Needs Higher Daily Vitamin D Supplement Doses To Achieve Immunity Effects

 

Table

View full table

Topics

Tags:
International Wellness Clinical Trials
Latest Headlines

US Health And Wellness People News: CHPA, Bayer, Viatris, Qnovia, Powerade

Women’s Voices For The Earth Will Keep After CIR, Salon Worker Safety In 2024

Haleon Real-World Study Shows Quality Of Life Improvement With Otrivine Use

Australian Teeth Whitener Marketer Frowns On Industry Self-Regulation Referencing US Laws

See All
UsernamePublicRestriction

Register

RS151433

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By